ADVANCED Eye Relief Redness Instant Relief 0.012 % / 0.2 % Ophthalmic Solution
RxNorm 1098366

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1098366 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ADVANCED Eye Relief Redness Instant Relief 0.012 % / 0.2 % Ophthalmic Solution.

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
Advanced Eye Relief Redness Instant Relief (naphazoline hydrochloride 0.012 % / PEG 300 0.2 % ) Ophthalmic Solution
AUI:3633871
View
PSN
ADVANCED Eye Relief Redness Instant Relief 0.012 % / 0.2 % Ophthalmic Solution
AUI:6403565
View
SBD
Naphazoline hydrochloride 0.12 mg/ML / polyethylene glycol 300 2 mg/ML Ophthalmic Solution [Advanced Eye Relief Redness Instant Relief]
AUI:12361054
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
Advanced Eye Relief Redness Instant Relief (naphazoline hydrochloride 0.012 % / PEG 300 0.2 % ) Ophthalmic Solution
(Atom ID: 3633871)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Advanced Eye Relief Redness Instant Relief (naphazoline hydrochloride 0.012 % / PEG 300 0.2 % ) Ophthalmic Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1098366
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3633871
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1098366
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PSN

Prescribable Name (PSN):
ADVANCED Eye Relief Redness Instant Relief 0.012 % / 0.2 % Ophthalmic Solution
(Atom ID: 6403565)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
ADVANCED Eye Relief Redness Instant Relief 0.012 % / 0.2 % Ophthalmic Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1098366
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6403565
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1098366
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SBD

Semantic Branded Drug (SBD):
Naphazoline hydrochloride 0.12 mg/ML / polyethylene glycol 300 2 mg/ML Ophthalmic Solution [Advanced Eye Relief Redness Instant Relief]
(Atom ID: 12361054)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
naphazoline hydrochloride 0.12 MG/ML / polyethylene glycol 300 2 MG/ML Ophthalmic Solution [Advanced Eye Relief Redness Instant Relief]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1098366
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12361054
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1098366
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1043641} 82054
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{360468} 8513
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1043641} 7247
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{360468} 8513
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1043641} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{360468} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXTERM FORM
Sol
The RxTerm dose form name for this drug